REG1A
Lithostathine-1-alpha
Also known as: PSP, PSPS, PSPS1, PTP, REG, REG1A_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P05451
- Gene
- REG1A
- Ensembl
- ENSG00000115386
- Chromosome
- 2
- Canonical length
- 166 aa
- Protein class
- Plasma proteins, Predicted secreted proteins, Transporters
- Secretome location
- Secreted to digestive system
OverviewNCBI Gene
This gene is a type I subclass member of the Reg gene family. The Reg gene family is a multigene family grouped into four subclasses, types I, II, III and IV, based on the primary structures of the encoded proteins. This gene encodes a protein that is secreted by the exocrine pancreas. It is associated with islet cell regeneration and diabetogenesis and may be involved in pancreatic lithogenesis. Reg family members REG1B, REGL, PAP and this gene are tandemly clustered on chromosome 2p12 and may have arisen from the same ancestral gene by gene duplication. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
166 residues, UniProt reviewed canonical sequence.
>P05451|REG1A
1 MAQTSSYFML ISCLMFLSQS QGQEAQTELP QARISCPEGT NAYRSYCYYF NEDRETWVDA
61 DLYCQNMNSG NLVSVLTQAE GAFVASLIKE SGTDDFNVWI GLHDPKKNRR WHWSSGSLVS
121 YKSWGIGAPS SVNPGYCVSL TSSTGFQKWK DVPCEDKFSF VCKFKNLocalizationUniProt · AlphaFold · HPA
Whether an antibody against REG1A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 108,892 nTPM
Expression across tissuesHPA
Tissue
- pancreas: 108,892 nTPM
- duodenum: 7,152 nTPM
- small intestine: 5,775 nTPM
- stomach: 891 nTPM
- rectum: 264 nTPM
- appendix: 188 nTPM
Single-cell type
- pancreatic acinar cells: 145,430 nCPM
- paneth cells: 13,126 nCPM
- enteric transient amplifying cells: 5,459 nCPM
- gastric chief cells: 5,044 nCPM
- enteric stem cells: 4,394 nCPM
- enterocytes: 3,751 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 0.1 nTPM
- amygdala: 0 nTPM
- basal ganglia: 0 nTPM
- cerebellum: 0 nTPM
- choroid plexus: 0 nTPM
- hippocampal formation: 0 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.54
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.31
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- antimicrobial humoral immune response mediated by antimicrobial peptide
- positive regulation of cell population proliferation
- response to peptide hormone
Molecular functions
- growth factor activity
- molecular function inhibitor activity
- oligosaccharide binding
- peptidoglycan binding
- signaling receptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads REG1A as an antibody target. Whether an autoantibody or antibody against REG1A could matter depends on whether native REG1A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
REG1A is annotated as secreted, so native REG1A circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label REG1A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...